Search Results

There are 30204 results for: content related to: A guide to the design and analysis of small clinical studies

  1. Bayesian design and analysis of composite endpoints in clinical trials with multiple dependent binary outcomes

    Pharmaceutical Statistics

    Volume 12, Issue 4, July/August 2013, Pages: 207–212, Boris G. Zaslavsky

    Article first published online : 29 APR 2013, DOI: 10.1002/pst.1572

  2. You have free access to this content
    Patterson S.D., Jones B. Simulation assessments of statistical aspects of bioequivalence in the pharmaceutical industry. Pharmaceutical Statistics 2004;3(1):13–23

    Pharmaceutical Statistics

    Volume 3, Issue 3, July/September 2004, Page: 232,

    Article first published online : 13 SEP 2004, DOI: 10.1002/pst.120

  3. Statistical considerations associated with a comprehensive regulatory framework to address the unmet need for new antibacterial therapies

    Pharmaceutical Statistics

    Volume 13, Issue 4, July/August 2014, Pages: 222–228, Aaron Dane and Jeffrey D. Wetherington

    Article first published online : 15 JUN 2014, DOI: 10.1002/pst.1625

  4. Literature Review October–December 2009

    Pharmaceutical Statistics

    Volume 9, Issue 1, January/March 2010, Pages: 84–85, S. Krishna Padmanabhan and Andrew Stone

    Article first published online : 8 FEB 2010, DOI: 10.1002/pst.415

  5. Literature Review January–March 2010

    Pharmaceutical Statistics

    Volume 9, Issue 2, April/June 2010, Pages: 168–169, S. Krishna Padmanabhan and Andrew Stone

    Article first published online : 30 APR 2010, DOI: 10.1002/pst.437

  6. Literature Review July–Sep 2009

    Pharmaceutical Statistics

    Volume 8, Issue 4, October/December 2009, Pages: 390–391, S. Krishna Padmanabhan and Andrew Stone

    Article first published online : 23 NOV 2009, DOI: 10.1002/pst.408

  7. List of referees for 2002 and 2003

    Pharmaceutical Statistics

    Volume 3, Issue 1, January/March 2004, Page: 73,

    Article first published online : 2 MAR 2004, DOI: 10.1002/pst.110

  8. Pharmaceutical Statistics 10th anniversary

    Pharmaceutical Statistics

    Volume 10, Issue 6, November/December 2011, Pages: 475–476, Katherine Hutchinson and John W. Stevens

    Article first published online : 2 DEC 2011, DOI: 10.1002/pst.534

  9. PSI's pharmaceutical statistics journal club

    Pharmaceutical Statistics

    Volume 10, Issue 1, January/February 2011, Page: iii, Julia Harris, Ann Cleverly and Mark Jones

    Article first published online : 28 JAN 2011, DOI: 10.1002/pst.487

  10. PSI's Pharmaceutical Statistics Journal Club

    Pharmaceutical Statistics

    Volume 11, Issue 3, May/June 2012, Page: 193, Rhiannon Maudsley, Ann Cleverly and Julia Harris

    Article first published online : 25 APR 2012, DOI: 10.1002/pst.1513

  11. Fitting Emax models to clinical trial dose–response data

    Pharmaceutical Statistics

    Volume 10, Issue 2, March/April 2011, Pages: 143–149, Simon Kirby, Phil Brain and Byron Jones

    Article first published online : 28 APR 2010, DOI: 10.1002/pst.432

  12. Editorial

    Pharmaceutical Statistics

    Volume 3, Issue 2, April/June 2004, Pages: 75–76, Christy Chuang-Stein, Byron Jones and Larry Furlong

    Article first published online : 15 JUN 2004, DOI: 10.1002/pst.122

  13. You have free access to this content
    Erratum: Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data

    Pharmaceutical Statistics

    Volume 10, Issue 2, March/April 2011, Pages: 187–189, Shuying Yang and James Roger

    Article first published online : 20 APR 2010, DOI: 10.1002/pst.436

    This article corrects:

    Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data

    Vol. 9, Issue 4, 313–330, Article first published online: 30 DEC 2009

  14. You have free access to this content
    A review of risk measures in pharmacoepidemiology with tips for statisticians in the pharmaceutical industry

    Pharmaceutical Statistics

    Volume 11, Issue 4, July/August 2012, Page: 349, George Quartey, Jixian Wang and Joseph Kim

    Article first published online : 21 MAY 2012, DOI: 10.1002/pst.1517

    This article corrects:

    A review of risk measures in pharmacoepidemiology with tips for statisticians in the pharmaceutical industry

    Vol. 10, Issue 6, 548–553, Article first published online: 30 NOV 2011

  15. Comment on ‘Inference on treatment effects for targeted clinical trials under enrichment design’, Jen-Pei Liu, Jr-Rung Lin, and Shein-Chung Chow; Pharmaceutical Statistics 2009; 8:356–370

    Pharmaceutical Statistics

    Volume 11, Issue 4, July/August 2012, Page: 342, Lin Chen and Yu-Xiu Liu

    Article first published online : 15 MAY 2012, DOI: 10.1002/pst.1519

  16. Comment on ‘morbidity measures in the presence of recurrent composite endpoints’, Scott M, Möcks J, Givens S, et al. Pharmaceutical Statistics 2003; 2(1):39–49

    Pharmaceutical Statistics

    Volume 4, Issue 1, January/March 2005, Pages: 71–73, Ming Zheng

    Article first published online : 23 FEB 2005, DOI: 10.1002/pst.152

  17. Comment on ‘Carry-over in cross-over trials in bioequivalence: theoretical concerns and empirical evidence’. Senn S, D'Angelo G, Potvin D. Pharmaceutical Statistics 2004; 3(2): 133–142

    Pharmaceutical Statistics

    Volume 4, Issue 3, July/September 2005, Pages: 215–216, Mary E. Putt

    Article first published online : 1 SEP 2005, DOI: 10.1002/pst.174

  18. Assessing the impact of ICH E9

    Pharmaceutical Statistics

    Volume 7, Issue 2, April/June 2008, Pages: 77–87, David Brown, Simon Day, Rob Hemmings and David Wright

    Article first published online : 28 APR 2008, DOI: 10.1002/pst.337

  19. Editorial

    Pharmaceutical Statistics

    Volume 5, Issue 2, April/June 2006, Page: 81, Steven A. Julious and Sue-Jane Wang

    Article first published online : 22 MAY 2006, DOI: 10.1002/pst.225

  20. More is less: A sample size curiosity

    Pharmaceutical Statistics

    Volume 2, Issue 3, July/September 2003, Page: 217, Peter Treasure

    Article first published online : 3 SEP 2003, DOI: 10.1002/pst.60